BMC Neuroscience, 2022 · DOI: 10.1186/s12868-022-00737-5 · Published: August 1, 2022
Spinal cord injury (SCI) often leads to long-term physical impairment. Currently, there are limited effective treatment options for this neurological disorder, focusing primarily on supportive measures. This research uses bioinformatics to analyze gene chip data from rats with subacute SCI to identify key biomarkers that could serve as targets for diagnosis and treatment. The study identified seven hub genes (Itgb1, Ptprc, Cd63, Lgals3, Vav1, Shc1, and Casp4) related to microglia activation, suggesting their potential as therapeutic targets for subacute SCI.
The seven identified hub genes (Itgb1, Ptprc, Cd63, Lgals3, Vav1, Shc1, and Casp4) could serve as potential therapeutic targets for subacute SCI.
The identified biological functions and pathways provide more detailed molecular mechanisms for understanding the progression of subacute SCI.
These hub genes can be further explored to balance the injury and repair processes induced by SCI.